AFINITOR 10 mg, comprimé — 3 plaquette(s) thermoformée(s) aluminium polyamide PVC de 10 comprimé(s) (Distributeur Parallèle : Abacus Medicine A/S)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400949501892
  • CIP7 4950189
  • CIS 64201368
  • Registration number EU/1/09/538

What the source publishes

Holder
NOVARTIS EUROPHARM (IRLANDE)
Active ingredients
ÉVÉROLIMUS
Form
comprimé
Package
3 plaquette(s) thermoformée(s) aluminium polyamide PVC de 10 comprimé(s) (Distributeur Parallèle : Abacus Medicine A/S)
Routes
orale
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
2009-08-03
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400949501892
{
  "cis": "64201368",
  "cip7": "4950189",
  "form": "comprimé",
  "name": "AFINITOR 10 mg, comprimé — 3 plaquette(s) thermoformée(s) aluminium polyamide PVC de 10 comprimé(s) (Distributeur Parallèle : Abacus Medicine A/S)",
  "cip13": "3400949501892",
  "holder": "NOVARTIS EUROPHARM (IRLANDE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "NOVARTIS EUROPHARM (IRLANDE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "1091.54",
  "authorisedOn": "2009-08-03",
  "compositions": [
    {
      "name": "ÉVÉROLIMUS",
      "nature": "SA",
      "strength": "10 mg",
      "linkageNumber": "1",
      "substanceCode": "94553",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": "1.02",
  "medicinePrice": "1090.52",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "AFINITOR 10 mg, comprimé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "3 plaquette(s) thermoformée(s) aluminium polyamide PVC de 10 comprimé(s) (Distributeur Parallèle : Abacus Medicine A/S)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "100 %"
  ],
  "marketingDeclaredOn": "2026-10-05",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "ÉVÉROLIMUS"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription réservée aux spécialistes et services HEMATOLOGIE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/09/538",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400949501892"